Pearl River Capital »

Crispr Therapeutics shares owned by Pearl River Capital

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Pearl River Capital from 13F filings

Historical chart of Pearl River Capital investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Pearl River Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Pearl River Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.4M 26k 54.01
2024-03-31 $406k 6.0k 68.16
2023-12-31 $423k 6.8k 62.60
2021-09-30 $320k 2.9k 111.81
2019-03-31 $252k 7.0k 35.75